Target species
Pigs, Dogs, Cats
Indications for use, specifying the target species
In dogs and cats, Lincoject is recommended for the treatment of infections caused by Lincomycin susceptible Gram-positive organisms, particularly streptococci and staphylococci and certain Gram-negative anaerobic bacteria (e.g. Bacteroides, Fusobacterium species).
Lincoject is recommended for treatment of the following conditions in dogs and cats: Tonsillitis, laryngitis and other respiratory tract infections; abscesses, infected wounds and purulent dermatitis; septicaemia.
In pigs, Lincoject is indicated for the treatment of infections caused by Lincomycin susceptible Gram-positive organisms (e.g. staphylococci, streptococci), certain Gram-negative anaerobic organisms (e.g. Serpulina (Treponema) hyodysenteriae, Bacteroids, Fusobacterium and Mycoplasma species).
Lincoject is recommended for treatment of the following conditions in pigs: Swine dysentry, enzootic or mycoplasmal pneumonia, septic arthritis, foot abscesses.
Contraindications
The use of Lincoject is not recommended in species other than the cat, dog and pig. Lincosamides may cause fatal enterocolitis in horses, rabbits and rodents and diarrhoea and reduced milk production in cattle.
Lincoject should not be given to animals with a known pre-existing monilial infection.
Not to be used in animals hypersensitive to Lincomycin
Special Warnings for each target species
When treating groups of pigs, the use of a multiple dose syringe is recommended. To refill the syringe, the use of a draw-off needle is recommended to avoid excessive broaching of the stopper.
Special precautions for use
Special precautions for use in animals
Do not exceed the recommended dosage.
Practice aseptic injection techniques.
Use of the product should be based on susceptibility testing of the bacteria isolated from the animal. If this is not possible, therapy should be based on local epidemiological information.
Special precautions to be taken by the person administering the veterinary medicinal product to animals
Avoid contact with the product. In case of accidental eye or skin contact, wash off the affected area thoroughly with water.
Adverse reactions (frequency and seriousness)
The intramuscular administration of Lincoject to pigs at higher levels than recommended may result in diarrhoea and loose stools.
Use during pregnancy, lactation or lay
Not applicable.
Interaction with other medicinal products and other forms of interaction
Not compatible with penicillin and erythromycin if used concurrently.
Amounts to be administered and administration route
Lincoject is indicated for intravenous and intramuscular administration to dogs and cats and intramuscular administration to pigs.
CATS AND DOGS:
Intramuscularly: 22 mg/kg of bodyweight once daily or 11 mg/kg every
12 hours.
Intravenously: 11 to 22 mg/kg one or two times per day by slow intravenous injection.
PIGS:
Intramuscularly: 4.5 to 11 mg/kg of bodyweight once daily.
To ensure the correct dosage, bodyweight should be determined as accurately as possible to avoid underdosing.
Overdose (symptoms, emergency procedures, antidotes), if necessary
The intramuscular administration of Lincoject to pigs at higher levels than recommended may result in diarrhoea and loose stools.
Withdrawal period
Animals must not be slaughtered for human consumption during treatment.
Pigs (Meat): 3 days